Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistanceMeghna Das Thakur, Darrin D. Stuart, Fernando Salangsang et al.|Nature|2013Cited by 735
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic DriverDhara N. Amin, Mark M. Moasser, Natalia Sergina et al.|Science Translational Medicine|2010Cited by 185
p53 constrains progression to anaplastic thyroid carcinoma in a <i>Braf</i> -mutant mouse model of papillary thyroid cancerDavid G. McFadden, Tyler Jacks, Amanda Vernon et al.|Proceedings of the National Academy of Sciences|2014Cited by 169
Oncogenic BRAF<sup>V600E</sup> inhibits BIM expression to promote melanoma cell survivalRobert A Cartlidge, Martin McMahon|Pigment Cell & Melanoma Research|2008Cited by 116
Isolation and Molecular Characterization of Circulating Melanoma CellsXi Luo, Daniel A. Haber, Anya M. Kimura et al.|Cell Reports|2014Cited by 109